Drug interactions
Droperidol + Indacaterol-glycopyrronium
Severity: Major
Droperidol and Indacaterol-glycopyrronium: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Droperidol can prolong the QT interval and carries a risk of torsade de pointes. Indacaterol may add to repolarization effects and lower potassium, raising arrhythmia risk, while droperidol may add mild anticholinergic effects.
What this interaction means in plain words
Droperidol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Additive QT prolongation with beta2-agonist induced hypokalemia.
What to do
Check ECG and correct potassium and magnesium before droperidol. Continue ECG monitoring and consider an alternative bronchodilator or antiemetic.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Droperidol and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Frequently asked questions
Can I take Droperidol with Indacaterol-glycopyrronium?
MediHelp rates the interaction as major. Droperidol and Indacaterol-glycopyrronium can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Droperidol can prolong the QT interval and carries a risk of torsade de pointes. Indacaterol may add to repolarization effects and lower potassium, raising arrhythmia risk, while droperidol may add mild anticholinergic effects.
How serious is the interaction between Droperidol and Indacaterol-glycopyrronium?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check ECG and correct potassium and magnesium before droperidol. Continue ECG monitoring and consider an alternative bronchodilator or antiemetic.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
